Literature DB >> 19304479

Metabolic prosthesis for oxygenation of ischemic tissue.

Elias Greenbaum1, Mark S Humayun, Charlene A Sanders, Dan Close, Hugh M O'Neill, Barbara R Evans.   

Abstract

This communication discloses new ideas and preliminary results on the development of a metabolic prosthesis for local oxygenation of ischemic tissue under physiologically neutral conditions. We report for the first time selective electrolysis of physiological saline by repetitively pulsed, charge-limited electrolysis for the production of oxygen and suppression of free chlorine. Using 800-microA amplitude current pulses and < 200 micros pulse duration, we demonstrate prompt oxygen production and delayed chlorine production at the surface of a fused 0.85-mm diameter spherical platinum electrode. The data, interpreted in terms of the ionic structure of the electric double layer, suggest a strategy for in situ production of metabolic oxygen via a new class of "smart" prosthetic implants for ischemic disease such as diabetic retinopathy. We also present data indicating that collateral pH drift, if any, can be held constant using a feedback-controlled three-electrode electrolysis system that chooses an anode and cathode pair based on pH data provided by a local sensor.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19304479     DOI: 10.1109/TBME.2008.2003263

Source DB:  PubMed          Journal:  IEEE Trans Biomed Eng        ISSN: 0018-9294            Impact factor:   4.538


  2 in total

1.  Monitoring of diisopropyl fluorophosphate hydrolysis by fluoride-selective polymeric films using absorbance spectroscopy.

Authors:  Madhumati Ramanathan; Lin Wang; James R Wild; Mark E Meyerhoff; Mark E Meyeroff; Aleksandr L Simonian
Journal:  Anal Chim Acta       Date:  2010-04-10       Impact factor: 6.558

2.  Vitreal oxygenation in retinal ischemia reperfusion.

Authors:  Walid Abdallah; Hossein Ameri; Ernesto Barron; Gerald J Chader; Elias Greenbaum; David R Hinton; Mark S Humayun
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-22       Impact factor: 4.799

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.